Kryxana Tablet (Ribociclib)
Kryxana Tablet contains Ribociclib, an oral targeted therapy used in combination with hormone treatment for HR-positive, HER2-negative advanced or metastatic breast cancer, working by inhibiting CDK4/6 proteins to slow cancer cell growth and progression.
Introduction Of Kryxana Tablet (Ribociclib)
Kryxana is a brand name of ribociclib, an anticancer medicine. Ribociclib belongs to a group of medicines called CDK 4/6 inhibitors (Cyclin-Dependent Kinase inhibitors).
It works by blocking certain proteins (CDK4 and CDK6) that help cancer cells grow and divide. By blocking these proteins, the medicine slows down or stops the growth of cancer cells.
It is taken orally (by mouth) as tablets, usually in cycles (for example, 21 days on treatment followed by 7 days off, as prescribed by a doctor).
Precautions of Kryxana Tablet (Ribociclib)
- Regular blood tests (WBC, liver function)
- ECG for heart rhythm monitoring
- Avoid pregnancy (use contraception)
- Avoid grapefruit & pomegranate
- Do not breastfeed
Uses of Kryxana Tablet
Kryxana Tablet (Ribociclib) is used for:
- Treatment of HR-positive, HER2-negative advanced breast cancer.
- Management of metastatic breast cancer.
- First-line therapy in combination with an aromatase inhibitor.
- Use in combination with fulvestrant after disease progression.
- Slowing the growth and spread of hormone-driven breast cancer cells.
- Improving progression-free survival in eligible patients.
- Targeted therapy as part of combination endocrine treatment plans.
Side Effects Of Kryxana Tablet (Ribociclib)
Common:
- Low white blood cells (infection risk)
- Nausea, vomiting
- Fatigue
- Hair thinning
- Diarrhea or constipation
Serious:
- Fever or infection signs
- Liver problems (yellow eyes/skin)
- Irregular heartbeat (QT prolongation)
- Severe breathing problems
FAQs Of Kryxana Tablet (Ribociclib)
1. How should Kryxana be taken?
It is taken orally, usually once daily for 21 consecutive days followed by 7 days off treatment (28-day cycle), or as directed by the oncologist.
2. Can Kryxana be taken alone?
It is generally prescribed in combination with hormone therapy, not as monotherapy.
3. What should I do if I miss a dose?
If a dose is missed or vomited, skip it and take the next dose at the scheduled time. Do not double the dose.
4. Is regular monitoring required?
Yes. Blood counts, liver function tests, and ECG monitoring are required during treatment.
5. Is Kryxana safe during pregnancy?
No. It may cause harm to the unborn baby. Effective contraception is required during treatment and for at least 3 weeks after the last dose.
6. Can patients breastfeed while on Kryxana?
Breastfeeding is not recommended during treatment and for at least 3 weeks after the last dose.
Interactions of Kryxana (Ribociclib)
- Concomitant use with strong CYP3A4 inhibitors may increase ribociclib plasma concentration and toxicity.
- Use with strong CYP3A4 inducers may significantly reduce therapeutic effectiveness.
- Co-administration with QT-prolonging agents may increase the risk of cardiac arrhythmias.
- Ribociclib may elevate exposure of CYP3A4 substrate medications, requiring dose adjustment.
- Avoid grapefruit, pomegranate, and St. John’s Wort during therapy.
- Patients should disclose all medications and supplements prior to initiation of treatment.
| Manufacturer | : | Novartis Ltd, India |
| Trade Name | : | |
| Generic Search | : | Ribociclib |
| Strength | : | 200mg, |
Latest Products
